Arkolith/Insider Trading/ONTX/Form 4

Fruchtman Steven M

PRESIDENT, CHIEF EXECUTIVE OFF, DirectorOnconova Therapeutics, Inc. (ONTX) · full profile →Form 4 · filed Feb 8, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2023Option exercise(M)21K——47K
Feb 7, 2023Tax withholding(F)7K$1.36$9K40K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 7, 2023Option exercise(M)21K—$043K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-002171) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML